The resistance mechanisms of ALK TKI are categorized into “on‐target” mechanisms such as ALK secondary resistance mutation or amplification, where oncogenic dependencies on ALK kinase persist, and “off‐target” mechanisms such as activation of bypass pathway or lineage changes, where the cancer cells can survive and proliferate regardless of ALK activity.8 This evidence concerns the gene ALK and cancer.